关注
Daniel Roche
Daniel Roche
University of Maryland School of Medicine
在 som.umaryland.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Neural substrates of cue reactivity: association with treatment outcomes and relapse
KE Courtney, JP Schacht, K Hutchison, DJO Roche, LA Ray
Addiction biology 21 (1), 3-22, 2016
2142016
Development of the neuroimmune modulator ibudilast for the treatment of alcoholism: a randomized, placebo-controlled, human laboratory trial
LA Ray, S Bujarski, S Shoptaw, DJO Roche, K Heinzerling, K Miotto
Neuropsychopharmacology 42 (9), 1776-1788, 2017
1112017
Alcohol, tobacco, and marijuana consumption is associated with increased odds of same-day substance co-and tri-use
DJO Roche, S Bujarski, R Green, EE Hartwell, AM Leventhal, LA Ray
Drug and alcohol dependence 200, 40-49, 2019
992019
Hormonal contraceptive use diminishes salivary cortisol response to psychosocial stress and naltrexone in healthy women
DJO Roche, AC King, AJ Cohoon, WR Lovallo
Pharmacology Biochemistry and Behavior 109, 84-90, 2013
892013
Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?
LA Ray, S Bujarski, MM Yardley, DJO Roche, EE Hartwell
The American journal of drug and alcohol abuse 43 (6), 703-710, 2017
752017
Subjective response to alcohol as a research domain criterion
LA Ray, S Bujarski, DJO Roche
Alcoholism: Clinical and Experimental Research 40 (1), 6-17, 2016
712016
The effects of naltrexone on subjective response to methamphetamine in a clinical sample: a double-blind, placebo-controlled laboratory study
LA Ray, S Bujarski, KE Courtney, NR Moallem, K Lunny, D Roche, ...
Neuropsychopharmacology 40 (10), 2347-2356, 2015
662015
Alcohol impairment of saccadic and smooth pursuit eye movements: impact of risk factors for alcohol dependence
DJO Roche, AC King
Psychopharmacology 212, 33-44, 2010
632010
Opportunities for the development of neuroimmune therapies in addiction
LA Ray, DJO Roche, K Heinzerling, S Shoptaw
International review of neurobiology 118, 381-401, 2014
602014
Ibudilast attenuates subjective effects of methamphetamine in a placebo-controlled inpatient study
MJ Worley, KG Heinzerling, DJO Roche, S Shoptaw
Drug and alcohol dependence 162, 245-250, 2016
572016
Varenicline potentiates alcohol‐induced negative subjective responses and offsets impaired eye movements
E Childs, DJO Roche, AC King, H de Wit
Alcoholism: Clinical and Experimental Research 36 (5), 906-914, 2012
512012
Sex differences in acute hormonal and subjective response to naltrexone: The impact of menstrual cycle phase
DJO Roche, AC King
Psychoneuroendocrinology 52, 59-71, 2015
492015
Naltrexone effects on subjective responses to alcohol in the human laboratory: A systematic review and meta‐analysis
LA Ray, RJ Green, DJO Roche, M Magill, S Bujarski
Addiction biology 24 (6), 1138-1152, 2019
462019
Differences in the subjective and motivational properties of alcohol across alcohol use severity: application of a novel translational human laboratory paradigm
S Bujarski, JD Jentsch, DJO Roche, VA Ramchandani, K Miotto, LA Ray
Neuropsychopharmacology 43 (9), 1891-1899, 2018
462018
The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users
S Bujarski, DJO Roche, K Lunny, NR Moallem, KE Courtney, V Allen, ...
Drug and alcohol dependence 142, 127-132, 2014
432014
Overcoming the “Valley of Death” in medications development for alcohol use disorder
LA Ray, S Bujarski, DJO Roche, M Magill
Alcoholism: Clinical and Experimental Research 42 (9), 1612-1622, 2018
422018
Acute alcohol response phenotype in heavy social drinkers is robust and reproducible
DJO Roche, MD Palmeri, AC King
Alcoholism: Clinical and Experimental Research 38 (3), 844-852, 2014
412014
Factor structure of subjective responses to alcohol in light and heavy drinkers
S Bujarski, KE Hutchison, DJO Roche, LA Ray
Alcoholism: clinical and experimental research 39 (7), 1193-1202, 2015
402015
Current insights into the mechanisms and development of treatments for heavy-drinking cigarette smokers
DJO Roche, LA Ray, MM Yardley, AC King
Current addiction reports 3, 125-137, 2016
382016
Acute HPA axis response to naltrexone differs in female vs. male smokers
DJO Roche, E Childs, AM Epstein, AC King
Psychoneuroendocrinology 35 (4), 596-606, 2010
382010
系统目前无法执行此操作,请稍后再试。
文章 1–20